DACOMITINIB

DACOMITINIB was reported 749 times

DACOMITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RET GENE FUSION POSITIVE 1 0.3333
1 BLOOD BILIRUBIN UNCONJUGATED DECREASED 2 0.0556
2 PRIDE SYNDROME 1 0.0526
3 MALIGNANT NEOPLASM OF PLEURA 3 0.0244
4 GLOBULIN ABNORMAL 1 0.0172
5 IMMATURE GRANULOCYTE PERCENTAGE INCREASED 1 0.0164
6 MEDIASTINAL SHIFT 1 0.0149
7 CATHETER CULTURE POSITIVE 1 0.0141
8 CARCINOEMBRYONIC ANTIGEN INCREASED 26 0.0134
9 PARONYCHIA 58 0.0132
10 NASAL MUCOSAL ULCER 1 0.0120
11 CORYNEBACTERIUM BACTERAEMIA 1 0.0118
12 PULMONARY SEPTAL THICKENING 1 0.0112
13 MEIBOMIANITIS 1 0.0111
14 RED BLOOD CELL NUCLEATED MORPHOLOGY PRESENT 1 0.0110
15 NEUROPATHIC MUSCULAR ATROPHY 1 0.0102
16 IMAGING PROCEDURE ABNORMAL 1 0.0100
17 SPLENIC GRANULOMA 1 0.0093
18 NAIL BED BLEEDING 5 0.0088
19 LARYNGEAL HAEMORRHAGE 1 0.0087
20 BODY MASS INDEX INCREASED 11 0.0081
21 BODY SURFACE AREA INCREASED 1 0.0078
22 PANCREATIC CALCIFICATION 1 0.0077
23 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL 1 0.0075
24 BENIGN NEOPLASM OF ADRENAL GLAND 1 0.0067
25 MUCOCUTANEOUS DISORDER 1 0.0063
26 PNEUMOBILIA 1 0.0060
27 PLEURAL THICKENING 4 0.0058
28 GLOBULINS INCREASED 2 0.0055
29 LUNG ADENOCARCINOMA STAGE IV 2 0.0052
30 ONYCHALGIA 5 0.0050
31 PULMONARY CALCIFICATION 2 0.0048
32 ADRENOMEGALY 1 0.0048
33 ELECTROCARDIOGRAM PR SHORTENED 1 0.0048
34 THYROXINE ABNORMAL 1 0.0047
35 EFFUSION 6 0.0044
36 ANGULAR CHEILITIS 3 0.0043
37 ORAL PUSTULE 1 0.0043
38 PLEURAL INFECTION 1 0.0043
39 NAIL BED INFECTION 1 0.0042
40 DERMATITIS INFECTED 2 0.0040
41 WHITE MATTER LESION 5 0.0040
42 PANCREATIC DUCT DILATATION 1 0.0036
43 REFRACTION DISORDER 1 0.0034
44 XEROPHTHALMIA 2 0.0034
45 VOCAL CORD INFLAMMATION 1 0.0034
46 MEAN PLATELET VOLUME INCREASED 2 0.0033
47 WRONG STRENGTH 1 0.0030
48 LUNG ADENOCARCINOMA 9 0.0030
49 LYMPHANGIOSIS CARCINOMATOSA 3 0.0029
50 TONGUE EXFOLIATION 1 0.0028
51 MONOCYTE PERCENTAGE INCREASED 2 0.0028
52 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
53 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2 0.0028
54 NON-SMALL CELL LUNG CANCER STAGE IV 1 0.0027
55 EGFR GENE MUTATION 1 0.0027
56 PHYSICAL EXAMINATION ABNORMAL 1 0.0026
57 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
58 CATHETER SITE EXTRAVASATION 1 0.0025
59 LARYNGEAL PAIN 1 0.0025
60 GRANULOCYTE COUNT INCREASED 1 0.0025
61 VULVAL ABSCESS 1 0.0024
62 GLUCOCORTICOID DEFICIENCY 1 0.0024
63 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
64 GLIOSIS 1 0.0023
65 NEOPLASM PROGRESSION 78 0.0022
66 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
67 CEREBRAL MICROHAEMORRHAGE 1 0.0022
68 EPIDERMOLYSIS 1 0.0022
69 PYOGENIC GRANULOMA 1 0.0021
70 INTRACRANIAL MASS 2 0.0021
71 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
72 TONGUE ERUPTION 1 0.0020
73 NECROTISING OESOPHAGITIS 1 0.0020
74 SKIN TOXICITY 11 0.0019
75 ENZYME ABNORMALITY 1 0.0019
76 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
77 BLADDER DILATATION 2 0.0018
78 DERMATITIS ACNEIFORM 11 0.0018
79 CARDIOPULMONARY FAILURE 7 0.0018
80 ENCEPHALOMALACIA 1 0.0018
81 METASTASES TO MENINGES 4 0.0018
82 OESOPHAGEAL STENOSIS 5 0.0018
83 HYPOVOLAEMIC SHOCK 8 0.0017
84 SITTING DISABILITY 1 0.0016
85 BLOOD BILIRUBIN DECREASED 1 0.0016
86 XEROSIS 2 0.0016
87 PLEURAL DISORDER 1 0.0016
88 METASTASES TO PELVIS 1 0.0016
89 PERIORAL DERMATITIS 1 0.0016
90 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
91 OESOPHAGEAL ACHALASIA 1 0.0016
92 C-REACTIVE PROTEIN DECREASED 1 0.0015
93 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
94 NAIL DISORDER 13 0.0015
95 SARS-COV-2 TEST NEGATIVE 1 0.0015
96 CUTANEOUS SYMPTOM 1 0.0015
97 NEUROENDOCRINE CARCINOMA 1 0.0014
98 NASAL INJURY 1 0.0014
99 SMALL CELL LUNG CANCER 2 0.0013
100 ASPIRATION PLEURAL CAVITY 1 0.0013
101 HAEMANGIOMA 3 0.0013
102 ORAL MUCOSAL ERYTHEMA 2 0.0013
103 OSTEOSCLEROSIS 2 0.0013
104 CROUP INFECTIOUS 1 0.0013
105 CEREBRAL ATROPHY 5 0.0013
106 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
107 BREAST OPERATION 1 0.0012
108 LUNG HYPERINFLATION 1 0.0012
109 BLOOD CHLORIDE INCREASED 2 0.0012
110 NON-SMALL CELL LUNG CANCER METASTATIC 1 0.0011
111 HILAR LYMPHADENOPATHY 1 0.0011
112 PROTEIN TOTAL INCREASED 3 0.0011
113 MOUTH ULCERATION 23 0.0011
114 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
115 NON-SMALL CELL LUNG CANCER 5 0.0010
116 HEPATIC MASS 2 0.0010
117 MIXED LIVER INJURY 3 0.0010
118 OSTEOLYSIS 2 0.0010
119 POSTICTAL STATE 1 0.0010
120 HYDROCELE 1 0.0009
121 SKIN EROSION 3 0.0009
122 PERIARTHRITIS 2 0.0009
123 BRAIN OPERATION 2 0.0009
124 CORTISOL DECREASED 1 0.0009
125 PALMAR ERYTHEMA 1 0.0009
126 TONGUE HAEMORRHAGE 1 0.0009
127 PUSTULE 2 0.0008
128 INFECTED CYST 1 0.0008
129 RASH PUSTULAR 6 0.0008
130 CEREBRAL ARTERY EMBOLISM 1 0.0008
131 EJECTION FRACTION ABNORMAL 1 0.0008
132 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
133 MUCOSAL INFLAMMATION 21 0.0008
134 DRUG ERUPTION 14 0.0008
135 CACHEXIA 4 0.0008
136 ACQUIRED GENE MUTATION 1 0.0008
137 CORNEAL ABRASION 1 0.0007
138 NAIL INFECTION 1 0.0007
139 INVESTIGATION ABNORMAL 1 0.0007
140 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
141 SUPERINFECTION 1 0.0007
142 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
143 MEAN CELL VOLUME DECREASED 1 0.0006
144 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
145 RESPIRATORY RATE DECREASED 2 0.0006
146 GASTROINTESTINAL TOXICITY 3 0.0006
147 BODY TEMPERATURE DECREASED 6 0.0006
148 SECOND PRIMARY MALIGNANCY 5 0.0006
149 GASTRIC DILATATION 1 0.0006
150 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
151 MALIGNANT PLEURAL EFFUSION 1 0.0006
152 SPLEEN DISORDER 1 0.0006
153 GLIOBLASTOMA 1 0.0006
154 VASCULAR PSEUDOANEURYSM 1 0.0006
155 OTORRHOEA 1 0.0006
156 LIVER INJURY 14 0.0006
157 NEUTROPENIC SEPSIS 4 0.0006
158 JOINT ARTHROPLASTY 1 0.0006
159 NASAL OEDEMA 1 0.0006
160 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
161 DYSENTERY 1 0.0005
162 TRAUMATIC LUNG INJURY 1 0.0005
163 DRUG-INDUCED LIVER INJURY 16 0.0005
164 SKIN DISORDER 17 0.0005
165 PROSTATOMEGALY 2 0.0005
166 GENE MUTATION 1 0.0005
167 BLOOD ALBUMIN DECREASED 4 0.0005
168 EMPYEMA 1 0.0005
169 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
170 CHEST INJURY 1 0.0005
171 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
172 PHARYNGEAL ERYTHEMA 1 0.0005
173 ABSCESS LIMB 2 0.0005
174 LUNG NEOPLASM 2 0.0005
175 RADIATION PNEUMONITIS 1 0.0005
176 MALIGNANT NEOPLASM PROGRESSION 45 0.0004
177 DENGUE FEVER 1 0.0004
178 ORAL PRURITUS 1 0.0004
179 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
180 LICHEN PLANUS 1 0.0004
181 PERFORMANCE STATUS DECREASED 2 0.0004
182 BILIRUBIN CONJUGATED INCREASED 1 0.0004
183 PULMONARY INFARCTION 1 0.0004
184 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
185 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
186 SMALL INTESTINAL OBSTRUCTION 5 0.0004
187 TACHYARRHYTHMIA 1 0.0004
188 ENDODONTIC PROCEDURE 1 0.0004
189 CANCER PAIN 1 0.0004
190 BLOOD CHLORIDE DECREASED 1 0.0004
191 FOLLICULITIS 4 0.0004
192 WHITE BLOOD CELL DISORDER 1 0.0004
193 CHOLESTASIS 7 0.0004
194 RHINALGIA 1 0.0004
195 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
196 SKIN FISSURES 7 0.0004
197 LUNG CONSOLIDATION 1 0.0004
198 SKIN HYPERTROPHY 1 0.0004
199 TUMOUR HAEMORRHAGE 1 0.0004
200 DRUG RESISTANCE 9 0.0004
201 LUNG CANCER METASTATIC 1 0.0003
202 STRABISMUS 1 0.0003
203 THORACIC VERTEBRAL FRACTURE 1 0.0003
204 PULMONARY MASS 5 0.0003
205 INGUINAL HERNIA 2 0.0003
206 PNEUMONIA VIRAL 1 0.0003
207 PULMONARY FIBROSIS 6 0.0003
208 PLEURAL EFFUSION 19 0.0003
209 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
210 BLOOD PRESSURE INCREASED 47 0.0003
211 LYMPHOCYTE COUNT INCREASED 1 0.0003
212 SKIN MASS 2 0.0003
213 METASTASES TO SPINE 1 0.0003
214 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
215 HEPATIC CYST 1 0.0003
216 SUDDEN CARDIAC DEATH 1 0.0003
217 HYPERBILIRUBINAEMIA 3 0.0003
218 BLOOD CREATININE ABNORMAL 1 0.0003
219 GRANULOMA 1 0.0003
220 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
221 JAUNDICE CHOLESTATIC 1 0.0003
222 FACIAL BONES FRACTURE 1 0.0003
223 TONGUE DISORDER 2 0.0003
224 DEATH 238 0.0003
225 MONOCYTE COUNT INCREASED 1 0.0003
226 MOUTH HAEMORRHAGE 2 0.0003
227 SEBORRHOEA 1 0.0003
228 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
229 WOUND HAEMORRHAGE 1 0.0003
230 NEURODERMATITIS 1 0.0003
231 HEPATIC FUNCTION ABNORMAL 10 0.0003
232 HYDRONEPHROSIS 2 0.0003
233 PROTEIN TOTAL DECREASED 1 0.0003
234 RASH 115 0.0003
235 PELVIC FRACTURE 2 0.0003
236 NAIL DISCOLOURATION 1 0.0003
237 OESOPHAGEAL PAIN 1 0.0003
238 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
239 FURUNCLE 2 0.0003
240 RED BLOOD CELL COUNT DECREASED 7 0.0002
241 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
242 HAEMOGLOBIN DECREASED 25 0.0002
243 HEART RATE INCREASED 24 0.0002
244 BLOOD UREA INCREASED 4 0.0002
245 DERMATITIS ALLERGIC 3 0.0002
246 PURULENT DISCHARGE 1 0.0002
247 METASTATIC NEOPLASM 1 0.0002
248 STOMATITIS 14 0.0002
249 DIVERTICULUM INTESTINAL 1 0.0002
250 SPINAL OSTEOARTHRITIS 2 0.0002
251 GINGIVAL SWELLING 1 0.0002
252 BLOOD CREATINE INCREASED 1 0.0002
253 SUSPECTED OFF LABEL USE 1 0.0002
254 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
255 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
256 SKIN LESION 6 0.0002
257 EAR DISORDER 1 0.0002
258 EYE OPERATION 1 0.0002
259 GASTRITIS EROSIVE 1 0.0002
260 UMBILICAL HERNIA 1 0.0002
261 SKIN REACTION 3 0.0002
262 CARDIAC TAMPONADE 1 0.0002
263 SUBCUTANEOUS ABSCESS 1 0.0002
264 TUMOUR MARKER INCREASED 1 0.0002
265 ATELECTASIS 2 0.0002
266 NASAL POLYPS 1 0.0002
267 SKIN HAEMORRHAGE 3 0.0002
268 FLUID INTAKE REDUCED 1 0.0002
269 DERMATITIS EXFOLIATIVE 1 0.0002
270 ERYSIPELAS 1 0.0002
271 PATHOLOGICAL FRACTURE 1 0.0002
272 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
273 CEREBRAL ISCHAEMIA 1 0.0002
274 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
275 SKIN ULCER 5 0.0002
276 SKIN NECROSIS 1 0.0002
277 PARTIAL SEIZURES 1 0.0002
278 DERMATITIS 4 0.0002
279 SERUM FERRITIN INCREASED 1 0.0002
280 DIARRHOEA 121 0.0002
281 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
282 SKIN LACERATION 2 0.0002
283 HYDROCEPHALUS 1 0.0002
284 CHOLELITHIASIS 6 0.0002
285 PROSTATIC DISORDER 1 0.0002
286 TRANSAMINASES INCREASED 4 0.0002
287 STREPTOCOCCAL INFECTION 1 0.0002
288 SCAB 2 0.0002
289 CHOLECYSTECTOMY 2 0.0002
290 GASTRIC HAEMORRHAGE 2 0.0002
291 MOUTH SWELLING 1 0.0002
292 BLOOD URIC ACID INCREASED 1 0.0002
293 PERICARDIAL EFFUSION 4 0.0002
294 COVID-19 PNEUMONIA 2 0.0002
295 HEPATIC FAILURE 5 0.0002
296 PLATELET COUNT ABNORMAL 1 0.0002
297 DRUG INTERACTION 26 0.0002
298 SCOLIOSIS 1 0.0002
299 BLEPHAROSPASM 1 0.0002
300 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
301 CARDIAC FLUTTER 1 0.0002
302 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
303 NODULE 2 0.0002
304 HAEMATOCRIT DECREASED 3 0.0002
305 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
306 QUALITY OF LIFE DECREASED 2 0.0001
307 BREAST MASS 1 0.0001
308 BRONCHIECTASIS 1 0.0001
309 FEEDING DISORDER 3 0.0001
310 INFARCTION 1 0.0001
311 ONYCHOCLASIS 1 0.0001
312 HYPERTRANSAMINASAEMIA 1 0.0001
313 HAEMOPTYSIS 4 0.0001
314 RIGHT VENTRICULAR FAILURE 1 0.0001
315 PAPULE 1 0.0001
316 DUODENAL ULCER 1 0.0001
317 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
318 UTERINE LEIOMYOMA 1 0.0001
319 ORAL DISORDER 1 0.0001
320 CEREBRAL DISORDER 1 0.0001
321 GLOSSODYNIA 3 0.0001
322 RASH PAPULAR 3 0.0001
323 APHTHOUS ULCER 1 0.0001
324 GASTROINTESTINAL INFLAMMATION 1 0.0001
325 NASAL DISCOMFORT 1 0.0001
326 RENAL CYST 1 0.0001
327 GINGIVAL PAIN 1 0.0001
328 RASH ERYTHEMATOUS 6 0.0001
329 DECREASED APPETITE 29 0.0001
330 BLOOD DISORDER 1 0.0001
331 INTERSTITIAL LUNG DISEASE 6 0.0001
332 CEREBRAL INFARCTION 3 0.0001
333 ABNORMAL FAECES 1 0.0001
334 HICCUPS 1 0.0001
335 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
336 EMBOLISM 1 0.0001
337 HEMIPLEGIA 1 0.0001
338 CARDIO-RESPIRATORY ARREST 5 0.0001
339 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
340 CANDIDA INFECTION 2 0.0001
341 HAEMATEMESIS 3 0.0001
342 FACIAL PARALYSIS 1 0.0001
343 SKIN SWELLING 1 0.0001
344 METASTASES TO LIVER 2 0.0001
345 HYPOXIA 4 0.0001
346 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
347 DRY SKIN 15 0.0001
348 PULMONARY OEDEMA 5 0.0001
349 JAUNDICE 3 0.0001
350 PAIN OF SKIN 3 0.0001
351 ANAL INCONTINENCE 1 0.0001
352 MYELOSUPPRESSION 4 0.0001
353 PNEUMONITIS 3 0.0001
354 PNEUMONIA BACTERIAL 1 0.0001
355 BRAIN NEOPLASM 1 0.0001
356 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
357 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
358 BLOOD SODIUM DECREASED 2 0.0001
359 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
360 SINUS BRADYCARDIA 1 0.0001
361 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
362 HEPATOMEGALY 1 0.0001
363 THERAPY CHANGE 1 0.0001
364 HOSPICE CARE 1 0.0001
365 BLADDER DISORDER 1 0.0001
366 BLOOD PRESSURE ABNORMAL 2 0.0001
367 SALIVARY HYPERSECRETION 1 0.0001
368 APHASIA 3 0.0001
369 EMPHYSEMA 1 0.0001
370 HELICOBACTER INFECTION 1 0.0001
371 MUSCULAR WEAKNESS 11 0.0001
372 EYE DISCHARGE 1 0.0001
373 NERVOUS SYSTEM DISORDER 3 0.0001
374 WEIGHT FLUCTUATION 1 0.0001
375 SCRATCH 1 0.0001
376 PULMONARY EMBOLISM 9 0.0001
377 FULL BLOOD COUNT ABNORMAL 1 0.0001
378 HYPOTHYROIDISM 3 0.0001
379 EATING DISORDER 2 0.0001
380 PLATELET COUNT DECREASED 10 0.0001
381 PRURITUS 36 0.0001
382 ACNE 7 0.0001
383 PRODUCT DISPENSING ERROR 2 0.0001
384 WOUND INFECTION 1 0.0001
385 EYE DISORDER 3 0.0001
386 LIVER DISORDER 4 0.0001
387 ORAL PAIN 2 0.0001
388 SKIN INFECTION 1 0.0001
389 BLOOD CALCIUM DECREASED 1 0.0001
390 CHROMATURIA 2 0.0001
391 GASTRIC DISORDER 3 0.0001
392 METASTASES TO LUNG 1 0.0001
393 ELECTROLYTE IMBALANCE 1 0.0001
394 EYELID OEDEMA 1 0.0001
395 VASCULITIS 1 0.0001
396 SPINAL PAIN 1 0.0001
397 OCULAR HYPERAEMIA 4 0.0001
398 ADRENAL INSUFFICIENCY 1 0.0001
399 RESPIRATORY FAILURE 6 0.0001
400 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
401 CARDIOMEGALY 1 0.0001
402 ILEUS 1 0.0001
403 TOOTH EXTRACTION 1 0.0001
404 SECRETION DISCHARGE 1 0.0001
405 BRAIN OEDEMA 1 0.0001
406 ACUTE KIDNEY INJURY 12 0.0001
407 HEPATITIS 2 0.0001
408 ERYTHEMA 16 0.0001
409 BLOOD CREATININE INCREASED 5 0.0001
410 DEAFNESS 2 0.0001
411 SPEECH DISORDER 4 0.0001
412 ANKYLOSING SPONDYLITIS 1 0.0001
413 BLOOD BILIRUBIN INCREASED 2 0.0001
414 ACUTE HEPATIC FAILURE 1 0.0001
415 LUNG NEOPLASM MALIGNANT 3 0.0001
416 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
417 PROCEDURAL PAIN 2 0.0001
418 ORAL DISCOMFORT 1 0.0001
419 APHONIA 1 0.0001
420 WEIGHT INCREASED 16 0.0001
421 BLOOD TEST ABNORMAL 1 0.0001
422 DYSPEPSIA 7 0.0001
423 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
424 SINUS TACHYCARDIA 1 0.0001
425 PARALYSIS 1 0.0001
426 HYPOACUSIS 3 0.0001
427 DYSSTASIA 2 0.0001
428 DYSPHONIA 4 0.0001
429 WEIGHT DECREASED 19 0.0001
430 ASCITES 2 0.0001
431 ILLNESS 7 0.0001
432 LABORATORY TEST ABNORMAL 2 0.0001
433 URINARY INCONTINENCE 2 0.0001
434 HAEMORRHAGE INTRACRANIAL 1 0.0001
435 RESPIRATORY DISORDER 2 0.0001
436 BLOOD POTASSIUM DECREASED 2 0.0001
437 ASTHENIA 25 0.0001
438 OEDEMA PERIPHERAL 8 0.0001
439 HYPOKALAEMIA 3 0.0001
440 ANKLE FRACTURE 1 0.0001
441 LUNG INFECTION 1 0.0001
442 EJECTION FRACTION DECREASED 1 0.0001
443 PYREXIA 22 0.0001
444 HEAD INJURY 2 0.0001
445 ULCER 1 0.0001
446 CYSTITIS 2 0.0001
447 DRUG INTOLERANCE 6 0.0001
448 BLOOD POTASSIUM INCREASED 1 0.0001
449 LUNG DISORDER 3 0.0001
450 METASTASES TO BONE 1 0.0001
451 STAPHYLOCOCCAL INFECTION 2 0.0001
452 PHOTOSENSITIVITY REACTION 1 0.0001
453 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
454 FEBRILE NEUTROPENIA 4 0.0001
455 VISUAL ACUITY REDUCED 2 0.0001
456 DRY EYE 3 0.0001
457 DEHYDRATION 8 0.0001
458 VOMITING 28 0.0001
459 SKIN EXFOLIATION 5 0.0001
460 DISEASE PROGRESSION 7 0.0001
461 HEMIPARESIS 1 0.0001
462 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
463 ECZEMA 3 0.0001
464 INTENTIONAL PRODUCT MISUSE 5 0.0001
465 HEART RATE DECREASED 2 0.0001
466 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
467 DYSPNOEA 32 0.0001
468 HEAD DISCOMFORT 1 0.0001
469 PNEUMONIA 18 0.0001
470 RASH PRURITIC 3 0.0001
471 TOOTHACHE 1 0.0001
472 C-REACTIVE PROTEIN INCREASED 2 0.0001
473 DYSURIA 2 0.0001
474 BLOOD GLUCOSE ABNORMAL 1 0.0001
475 CONJUNCTIVITIS 1 0.0001
476 AGRANULOCYTOSIS 1 0.0001
477 SWELLING 5 0.0001
478 OXYGEN SATURATION DECREASED 3 0.0001
479 GASTRIC ULCER 1 0.0001
480 PROTEINURIA 1 0.0001
481 INCREASED APPETITE 1 0.0001
482 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
483 POST PROCEDURAL COMPLICATION 1 0.0001
484 HERNIA 1 0.0001
485 BONE PAIN 3 0.0001
486 CATARACT 3 0.0001
487 UPPER LIMB FRACTURE 1 0.0001
488 CARDIAC FAILURE 4 0.0000
489 VERTIGO 3 0.0000
490 NEUTROPHIL COUNT DECREASED 2 0.0000
491 RIB FRACTURE 1 0.0000
492 CARDIAC ARREST 4 0.0000
493 PULMONARY HYPERTENSION 1 0.0000
494 HAEMORRHAGE 5 0.0000
495 RENAL FAILURE ACUTE 2 0.0000
496 RETCHING 1 0.0000
497 COUGH 13 0.0000
498 BALANCE DISORDER 4 0.0000
499 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
500 SWELLING FACE 3 0.0000
501 SEPTIC SHOCK 2 0.0000
502 MENTAL DISORDER 2 0.0000
503 PRODUCT PRESCRIBING ISSUE 1 0.0000
504 MELAENA 1 0.0000
505 STEVENS-JOHNSON SYNDROME 1 0.0000
506 TOOTH DISORDER 1 0.0000
507 RASH MACULO-PAPULAR 1 0.0000
508 GASTROINTESTINAL DISORDER 4 0.0000
509 PANCREATITIS ACUTE 1 0.0000
510 PAIN 27 0.0000
511 SKIN DISCOLOURATION 2 0.0000
512 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
513 BURNING SENSATION 3 0.0000
514 CARDIAC DISORDER 4 0.0000
515 PRODUCT USE ISSUE 8 0.0000
516 DYSPHAGIA 4 0.0000
517 PRODUCT PRESCRIBING ERROR 1 0.0000
518 ANAEMIA 8 0.0000
519 BLOOD PRESSURE FLUCTUATION 1 0.0000
520 TOXICITY TO VARIOUS AGENTS 7 0.0000
521 LOCALISED INFECTION 1 0.0000
522 CONSTIPATION 9 0.0000
523 MENTAL IMPAIRMENT 1 0.0000
524 HYPOGLYCAEMIA 2 0.0000
525 PRESYNCOPE 1 0.0000
526 ATRIAL FIBRILLATION 4 0.0000
527 EPISTAXIS 3 0.0000
528 AGEUSIA 1 0.0000
529 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
530 GASTRIC CANCER 1 0.0000
531 DIABETES MELLITUS 3 0.0000
532 OFF LABEL USE 34 0.0000
533 RASH GENERALISED 1 0.0000
534 GASTRITIS 1 0.0000
535 CHEST PAIN 7 0.0000
536 HYPERTENSION 8 0.0000
537 MENSTRUATION IRREGULAR 1 0.0000
538 FREQUENT BOWEL MOVEMENTS 1 0.0000
539 LIMB INJURY 1 0.0000
540 PALLOR 1 0.0000
541 MOOD ALTERED 1 0.0000
542 HAEMATOCHEZIA 2 0.0000
543 RESPIRATORY DISTRESS 1 0.0000
544 MENTAL STATUS CHANGES 1 0.0000
545 WOUND 1 0.0000
546 THROMBOCYTOPENIA 4 0.0000
547 RENAL IMPAIRMENT 3 0.0000
548 BLISTER 2 0.0000
549 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
550 INTENTIONAL DOSE OMISSION 1 0.0000
551 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
552 HYPERSOMNIA 1 0.0000
553 SEIZURE 4 0.0000
554 ABDOMINAL PAIN 8 0.0000
555 COVID-19 6 0.0000
556 TACHYCARDIA 3 0.0000
557 WHEEZING 2 0.0000
558 LACRIMATION INCREASED 1 0.0000
559 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
560 HYPERSENSITIVITY 6 0.0000
561 LIMB DISCOMFORT 1 0.0000
562 FATIGUE 25 0.0000
563 GAIT DISTURBANCE 6 0.0000
564 MOVEMENT DISORDER 1 0.0000
565 RHINORRHOEA 2 0.0000
566 DEEP VEIN THROMBOSIS 2 0.0000
567 BACK PAIN 7 0.0000
568 BLOOD PRESSURE DECREASED 2 0.0000
569 FUNGAL INFECTION 1 0.0000
570 URINARY RETENTION 1 0.0000
571 GAIT INABILITY 1 0.0000
572 ANGER 1 0.0000
573 CHEST DISCOMFORT 3 0.0000
574 HAEMATURIA 1 0.0000
575 MEMORY IMPAIRMENT 4 0.0000
576 DELIRIUM 1 0.0000
577 ABDOMINAL DISTENSION 3 0.0000
578 RASH MACULAR 1 0.0000
579 HYPERKALAEMIA 1 0.0000
580 ANXIETY 8 0.0000
581 CEREBRAL HAEMORRHAGE 1 0.0000
582 HYPERGLYCAEMIA 1 0.0000
583 RESTLESSNESS 1 0.0000
584 SEPSIS 3 0.0000
585 DYSPNOEA EXERTIONAL 1 0.0000
586 CHILLS 3 0.0000
587 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
588 NAUSEA 20 0.0000
589 DISORIENTATION 1 0.0000
590 HYPOTENSION 5 0.0000
591 DRY MOUTH 2 0.0000
592 VISUAL IMPAIRMENT 3 0.0000
593 PAIN IN EXTREMITY 7 0.0000
594 OSTEOARTHRITIS 1 0.0000
595 URINARY TRACT INFECTION 4 0.0000
596 RECTAL HAEMORRHAGE 1 0.0000
597 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
598 ANGIOEDEMA 1 0.0000
599 HEADACHE 14 0.0000
600 THROAT IRRITATION 1 0.0000
601 THERAPY NON-RESPONDER 1 0.0000
602 SKIN IRRITATION 1 0.0000
603 NEPHROLITHIASIS 1 0.0000
604 RENAL DISORDER 1 0.0000
605 BLOOD CHOLESTEROL INCREASED 1 0.0000
606 COGNITIVE DISORDER 1 0.0000
607 COMA 1 0.0000
608 PRODUCTIVE COUGH 1 0.0000
609 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
610 MALAISE 9 0.0000
611 LEUKOPENIA 1 0.0000
612 AGGRESSION 1 0.0000
613 SOMNOLENCE 4 0.0000
614 HOSPITALISATION 3 0.0000
615 THERAPY CESSATION 1 0.0000
616 INFLAMMATION 1 0.0000
617 DEPRESSED MOOD 1 0.0000
618 CONFUSIONAL STATE 3 0.0000
619 OEDEMA 1 0.0000
620 DIZZINESS 9 0.0000
621 NECK PAIN 1 0.0000
622 PANCYTOPENIA 1 0.0000
623 HYPONATRAEMIA 1 0.0000
624 EYE PAIN 1 0.0000
625 MYALGIA 3 0.0000
626 FLATULENCE 1 0.0000
627 CONVULSION 1 0.0000
628 NASAL CONGESTION 1 0.0000
629 PRODUCT DOSE OMISSION ISSUE 5 0.0000
630 THERAPEUTIC RESPONSE DECREASED 1 0.0000
631 CONDITION AGGRAVATED 5 0.0000
632 MUSCLE SPASMS 3 0.0000
633 NASOPHARYNGITIS 3 0.0000
634 BLOOD GLUCOSE INCREASED 3 0.0000
635 PRODUCT DOSE OMISSION 1 0.0000
636 FALL 5 0.0000
637 NEOPLASM MALIGNANT 1 0.0000
638 SLEEP DISORDER 1 0.0000
639 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
640 THERAPY INTERRUPTED 1 0.0000
641 UNDERDOSE 1 0.0000
642 HYPOAESTHESIA 2 0.0000
643 HALLUCINATION 1 0.0000
644 CHRONIC KIDNEY DISEASE 1 0.0000
645 PERIPHERAL SWELLING 2 0.0000
646 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
647 MYOCARDIAL INFARCTION 2 0.0000
648 NEUROPATHY PERIPHERAL 1 0.0000
649 SYNCOPE 1 0.0000
650 FLUSHING 1 0.0000
651 SINUSITIS 1 0.0000
652 ABDOMINAL PAIN UPPER 2 0.0000
653 ASTHMA 1 0.0000
654 INCORRECT DOSE ADMINISTERED 2 0.0000
655 FEELING ABNORMAL 2 0.0000
656 EMOTIONAL DISTRESS 1 0.0000
657 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
658 LOSS OF CONSCIOUSNESS 1 0.0000
659 RENAL FAILURE 1 0.0000
660 INSOMNIA 2 0.0000
661 NEUTROPENIA 1 0.0000
662 VISION BLURRED 1 0.0000
663 ARTHRALGIA 3 0.0000
664 INFECTION 1 0.0000
665 DRUG INEFFECTIVE 9 0.0000
666 PARAESTHESIA 1 0.0000
667 TREMOR 1 0.0000
668 URTICARIA 1 0.0000
669 ABDOMINAL DISCOMFORT 1 0.0000
670 CEREBROVASCULAR ACCIDENT 1 0.0000
671 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
672 ALOPECIA 1 0.0000